Pharmaceutical Analysis & Statistics, October 2014 (p100)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: therapeutics, drug, cancer, more »

2971-3010 of about 19 000 reports

Purchase Reports From Reputable Market Research Publishers

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary EpiZyme, Inc. (Epizyme) is a biopharmaceutical company. The company discovers and develops molecular targeted drugs for the treatment of oncology and metabolic diseases. Epizyme's products include ...

  • Industries : Pathology
  • Countries : United States
KaloBios Pharmaceuticals, Inc. (KBIO) - Financial and Strategic SWOT Analysis Review

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary KaloBios Pharmaceuticals, Inc. (KaloBios) is a biopharmaceutical company. The company develops monoclonal antibodies for the treatment of severe respiratory diseases and cancer. KaloBios's products ...

  • Industries : Pathology
  • Countries : United States
Intrexon Corporation (XON) - Financial and Strategic SWOT Analysis Review

Intrexon Corporation (XON) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Intrexon Corporation (Intrexon) is a biotechnology company. The company develops solutions for current and looming challenges. It operates through divisions, such as human therapeutics, protein ...

  • Industries : Pathology
  • Countries : United States
Heat Biologics, Inc. (HTBX) - Financial and Strategic SWOT Analysis Review

Heat Biologics, Inc. (HTBX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Heat Biologics, Inc. (Heat Biologics) is a clinical-stage biopharmaceutical company. It focuses on developing its novel, "off-the-shelf" ImPACT (Immune Pan-Antigen Cytotoxic Therapy) therapeutic ...

  • Industries : Pathology
OncoMed Pharmaceuticals, Inc. (OMED) - Financial and Strategic SWOT Analysis Review

OncoMed Pharmaceuticals, Inc. (OMED) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary OncoMed Pharmaceuticals, Inc. (OncoMed) is a biotechnology company. The company discovers and develops monoclonal antibody therapeutics. Its product pipeline includes demcizumab, OMP-59R5, vantictumab, ...

  • Industries : Pharmaceutical
  • Countries : United States
Regado Biosciences, Inc. (RGDO) - Financial and Strategic SWOT Analysis Review

Regado Biosciences, Inc. (RGDO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Regado Biosciences, Inc. (Regado) is a pharmaceutical company. The company discovers and develops actively controllable antithrombotic drug systems for acute and sub acute cardiovascular indications. ...

  • Industries : Drug and Medication
  • Countries : United States
Prosensa Holding B.V. - Strategic SWOT Analysis Review

Prosensa Holding B.V. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Prosensa Holding B.V. (Prosensa) is a biopharmaceutical company. The company discovers, develops, and commercializes products for the healthcare market based on RNA-based therapeutics. It targets ...

  • Industries : Pathology
  • Countries : Netherlands
Onconova Therapeutics, Inc. (ONTX) - Financial and Strategic SWOT Analysis Review

Onconova Therapeutics, Inc. (ONTX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Onconova Therapeutics, Inc. (Onconova) is a biopharmaceutical company. The company discovers and develops novel small molecule drug candidates to treat cancer. It develops targeted anti-cance ...

  • Industries : Therapy
  • Countries : United States
Stemline Therapeutics, Inc. (STML) - Financial and Strategic SWOT Analysis Review

Stemline Therapeutics, Inc. (STML) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Stemline Therapeutics, Inc. (Stemline) is a clinical stage biopharmaceutical company. The company develops oncology compounds, which targets both cancer stem cells (CSC's) and the tumor bulk. Its ...

  • Industries : Therapy
  • Countries : United States
Handok Inc. (002390) - Financial and Strategic SWOT Analysis Review

Handok Inc. (002390) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Handok Inc. (Handok) formerly Handok Pharmaceuticals Co., Ltd. is a pharmaceuticals and healthcare company, based in South Korea. The company carries out the discovery, development, manufacture ...

  • Industries : Prescription Drug
  • Countries : South Korea
Easton Pharmaceuticals Inc. (EAPH) - Financial and Strategic SWOT Analysis Review

Easton Pharmaceuticals Inc. (EAPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Easton Pharmaceuticals Inc. (Easton Pharmaceuticals) is a specialty pharmaceutical company. The company designs, develops and markets topically delivered therapeutic health care products. It offers ...

  • Industries : Pharmaceutical
  • Countries : Canada, United States
Lee%s Pharmaceutical Holdings Limited (950) - Financial and Strategic SWOT Analysis Review

Lee%s Pharmaceutical Holdings Limited (950) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Lee's Pharmaceutical Holdings Limited (Lee's Pharm) is a pharmaceutical company. It comprises of four GMP-compliant workshops. The company undertakes the production of lyophilized powder for injection, ...

  • Industries : Pharmaceutical
Prima BioMed Ltd. (PRR) - Financial and Strategic SWOT Analysis Review

Prima BioMed Ltd. (PRR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Prima BioMed Ltd. (Prima BioMed) is a biotechnology company. The company develops personalized immunocellular therapeutic products for cancer treatment. Its CVac therapy is an immunocellular therapeutic ...

  • Industries : Pathology
  • Countries : Australia
REVA Medical, Inc. (RVA) - Financial and Strategic SWOT Analysis Review

REVA Medical, Inc. (RVA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary REVA Medical, Inc. (REVA Medical) is a medical device company. The company develops minimally invasive medical devices. Its products include bioresorbable polymers. REVA Medical offers products ...

  • Industries : Pathology
  • Countries : United States
MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review

MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary MEI Pharma, Inc. (MEI) is an oncology company. The company provides clinical development of therapeutics for the treatment of cancer. It develops cancer therapeutic with the help of naturally occurring ...

  • Industries : Pathology
  • Countries : United States
Titan Pharmaceuticals, Inc. (TTNPE) - Financial and Strategic SWOT Analysis Review

Titan Pharmaceuticals, Inc. (TTNPE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Titan Pharmaceuticals, Inc. (Titan Pharmaceuticals) is a biopharmaceutical company. The company develops therapeutics for the treatment of central nervous system disorders. Its products include ...

  • Industries : Pharmaceutical
  • Countries : United States
SOHM Inc. - Strategic SWOT Analysis Review

SOHM Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary SOHM Inc. (SOHM) is a pharmaceutical company. The company manufactures and markets generic, pharmaceuticals, over the counter, cosmeceuticals and nutraceutical products for healthcare market. Its ...

  • Industries : Drug and Medication
Trius Therapeutics, Inc. - Strategic SWOT Analysis Review

Trius Therapeutics, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Trius Therapeutics, Inc. (Trius) is a biopharmaceutical company. The company discovers, develops and commercializes antibiotics for life-threatening infections. It has completed Phase 3 clinical ...

  • Industries : Therapy
  • Countries : United States
Taisho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis Review

Taisho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Taisho Pharmaceutical Co., Ltd. (Taisho) is a pharmaceutical company. The company carries out the development, manufacture and marketing of various pharmaceutical products. Its products include ...

  • Industries : Pharmaceutical
  • Countries : Philippines, Japan, United States, Australia, Indonesia, Asia, Vietnam, Thailand, Taiwan, Malaysia, China
VG Life Sciences, Inc. (VGLS) - Financial and Strategic SWOT Analysis Review

VG Life Sciences, Inc. (VGLS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary VG Life Sciences, Inc. (VG Life Sciences) is a drug discovery and development company. The company discovers and develops drugs and treatments for cancer, infectious disease, and inflammation. ...

  • Industries : Pathology
  • Countries : United States
Vyteris, Inc. - Strategic SWOT Analysis Review

Vyteris, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Vyteris, Inc. (Vyteris) is a biotechnology company. The company discovers, develops, and manufactures transdermal medication delivery products, which delivers drugs through skin using low-level ...

  • Industries : Pathology
  • Countries : United States
DATATRAK International, Inc. (DTRK) - Financial and Strategic SWOT Analysis Review

DATATRAK International, Inc. (DTRK) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary DATATRAK International, Inc. (DATATRAK) is a healthcare information technology company. The company provides e-clinical solutions and related services for the clinical trials industry. Its products ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Piramal Enterprises Limited (PEL) - Financial and Strategic SWOT Analysis Review

Piramal Enterprises Limited (PEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Piramal Enterprises Limited (PEL) is a diversified company. The company offers healthcare information management, life sciences and drug delivery systems, financial services and contract manufacturing ...

  • Industries : Drug Discovery and Development
  • Countries : India
Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Veropharm is a pharmaceutical company. The company develops and manufactures generic pharmaceutical drugs, oncological medications, and medical adhesive bandages. It operates through three plants, ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Bafna Pharmaceuticals Limited (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review

Bafna Pharmaceuticals Limited (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Bafna Pharmaceuticals Limited (Bafna Pharmaceuticals) is a pharmaceutical company. The company manufactures and markets a range of pharmaceutical products. Its operations include domestic marketing, ...

  • Industries : Pharmaceutical
  • Countries : Australia
Antibiotice SA (ATB) - Financial and Strategic SWOT Analysis Review

Antibiotice SA (ATB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Antibiotice SA (Antibiotice) is a drug manufacturing company. The company produces a wide range of medicines covering therapeutic areas such as anti-infective, cardiovascular, digestive, central ...

  • Industries : Drug and Medication
Protek OAO (PRTK) - Financial and Strategic SWOT Analysis Review

Protek OAO (PRTK) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Protek is a pharmaceutical company. The company manufactures, sells and distributes pharmaceutical, health and beauty care products. Its products include CV Protek, Sotex Farm and Rigla Pharmacy ...

  • Industries : Pharmaceutical
  • Countries : Russian Federation
Portola Pharmaceuticals, Inc. (PTLA) - Financial and Strategic SWOT Analysis Review

Portola Pharmaceuticals, Inc. (PTLA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company. It undertakes the discovery and development of innovative therapeutics for the treatment of cardiovascular, inflammation, ...

  • Industries : Pathology
  • Countries : United States
Carespot Express Healthcare - Strategic SWOT Analysis Review

Carespot Express Healthcare - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Carespot Express Healthcare (CareSpot) is a healthcare service provider. The center offers healthcare and urgent care services. It offers urgent care, well care and occupational health services. ...

  • Industries : Pathology
  • Countries : United States
CMG Pharmaceutical Co., Ltd. (058820) - Financial and Strategic SWOT Analysis Review

CMG Pharmaceutical Co., Ltd. (058820) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary CMG Pharmaceutical Co., Ltd. (CMG Pharmaceutical) is a pharmaceutical company, based in Korea. The company manufactures and sells pharmaceutical, health food and non-pharmaceutical products. It ...

  • Industries : Drug and Medication
  • Countries : South Korea
About 57 000 reports

Download Unlimited Documents from Trusted Public Sources

E-cigarette Market Forecast in the UK

  • Advertising of E-cigarettes
  • October 2014
    9 pages
  • E-cigarette  

    Smoking Treatme...  

  • United Kingdom  

    Europe  

View report >

Medication Market

October 2014

About 400 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.